This Week in BMC Cancer

Premium

In BMC Cancer this week, researchers in Sweden and Finland report that DYX1C1, the dyslexia candidate gene, may serve as a prognostic marker in patients with breast cancer. DYX1C1 has been shown to regulate and interact with estrogen receptors, the researchers write. For this study, the team assessed the gene's mRNA expression in three patient cohorts, and found that DYX1C1 mRNA is significantly more highly expressed in breast tumor classified as ER-alpha and PR-positive.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.